The RAVAYA Guide to Blue, Red and Near-Infrared Light

RAVAYA Light uses four wavelengths in its Advanced-Spectrum Mask:

• 465 nm blue light
• 630 nm red light
• 850 nm near-infrared light
• 1070 nm near-infrared light

The current RAVAYA website groups these wavelengths into five selectable modes.

The presence of four wavelengths does not mean that all four perform the same function, have equally strong research support, or can be evaluated using the same biological explanation.

Blue light is visible and is most often studied in relation to acne and microbial porphyrins. Red and near-infrared light are commonly studied within photobiomodulation research involving cellular signaling and facial rejuvenation. The evidence surrounding approximately 1070–1072 nm is newer and substantially smaller than the evidence base for conventional red and shorter near-infrared wavelengths.

This guide explains what each wavelength means, what researchers have actually studied, where the findings are promising, and which marketing conclusions go beyond the available evidence.

What you should know

A wavelength identifies the distance between repeating peaks in a light wave. It does not, by itself, determine whether a finished device will produce a specific result.

The biological exposure also depends on:

• Irradiance
• Treatment time
• Total delivered dose
• Pulse behavior
• LED placement
• Distance from the skin
• Facial coverage
• Uniformity
• Skin characteristics
• Treatment frequency
• Device construction

Two masks that both advertise 630 nm may deliver substantially different exposures.

Research involving one mask therefore cannot be transferred automatically to every other device using the same nominal wavelength.

Key takeaways

• 465 nm is blue visible light. The broader blue-light acne literature is promising but heterogeneous, and much of the frequently cited evidence uses wavelengths nearer 415 nm rather than exactly 465 nm.
• 630 nm has meaningful facial-rejuvenation research. Human studies have evaluated 630 nm alone and in combination with near-infrared wavelengths.
• 850 nm is usually studied as part of a combination. Much of the relevant facial-mask evidence evaluates red and 850 nm together rather than isolated 850 nm treatment.
• 1070 nm remains an emerging wavelength. Limited human research does not establish claims involving facial-muscle treatment, jawline sculpting or lymphatic drainage.
• Longer wavelength does not automatically mean better treatment.
• A studied wavelength is not the same as a clinically proven finished product.
• Dose and coverage are as important as the wavelength label.

What is a wavelength?

Light is a form of electromagnetic radiation. Wavelength describes the distance between successive peaks of a wave and is commonly measured in nanometers.

One nanometer, abbreviated nm, is one billionth of a meter.

Human eyes perceive some wavelengths as colors. Other wavelengths, including much of the near-infrared spectrum, are ordinarily invisible.

In simplified terms:

• Shorter visible wavelengths include violet and blue.
• Longer visible wavelengths include orange and red.
• Near-infrared begins beyond visible red.

These categories are useful, but the boundaries are not perfectly rigid. Scientific sources may use slightly different ranges when defining visible red and near-infrared light.

Visible does not mean active, and invisible does not mean inactive

Blue and red light can be seen by the human eye.

Near-infrared light usually cannot.

The fact that a wavelength is invisible does not mean it is not being emitted or absorbed. It also does not mean that invisible light is automatically more powerful or effective.

Biological activity depends on what absorbs the light and how much usable energy reaches the relevant tissue.

For a general explanation of these mechanisms, read How Photobiomodulation Works.

RAVAYA wavelength overview

This table describes the research landscape. It is not a guarantee that the RAVAYA mask produces each possible outcome.

465 nm blue light

What is 465 nm light?

465 nm is visible blue light.

Blue light uses different photoacceptors and biological pathways from those most often discussed for red and near-infrared photobiomodulation.

In acne research, an important proposed mechanism involves porphyrins produced by Cutibacterium acnes. When these porphyrins absorb suitable blue or violet-blue light, reactive molecules may be generated that can damage bacterial cells under appropriate conditions.

Acne is not simply a bacterial infection, however. It also involves follicular blockage, sebum, inflammation, hormonal influences, genetics and individual skin response.

Blue light should therefore not be described as a complete solution for every form of acne.

What has been studied?

Many of the best-known blue-light acne trials have used wavelengths close to 405–420 nm.

For example, a randomized study of 107 people with mild-to-moderate acne evaluated 415 nm blue light, a combination of 415 nm blue and 660 nm red light, white light and benzoyl peroxide. That study is relevant to the broader blue-light category, but it did not test 465 nm or the RAVAYA mask.

A 2019 systematic review evaluated 14 blue-light acne trials involving 698 participants. Most trials were small, lasted less than 12 weeks and were judged to have a high risk of bias. Some reported improvement, but the review concluded that the certainty of the evidence remained limited.

A newer systematic review and meta-analysis published in 2025 included six studies of portable or at-home LED acne devices. It found encouraging results, particularly for red-and-blue combinations, while also identifying substantial differences among devices, doses and protocols. The review authors cautioned against assuming that the findings apply to every device on the market.

What about exactly 465 nm?

The existence of broader blue-light acne research does not mean that all blue wavelengths are interchangeable.

A 2025 study specifically involving 465 nm blue light reported favorable findings, but the treatment combined the light with photoacceptor substances. That makes it materially different from ordinary use of a bare-skin LED mask and prevents the results from being treated as direct evidence for the RAVAYA 465 nm mode.

The responsible conclusion is:

Blue-light acne research provides a scientific rationale for studying 465 nm, but the exact RAVAYA wavelength, dose, mode combination and finished device require their own applicable evidence.

What 465 nm may reasonably be discussed for

Carefully worded educational content may state that:

• Blue light has been studied for mild-to-moderate acne.
• Some at-home blue and red-blue devices have reported improvements in inflammatory acne outcomes.
• Blue-light effects can depend on the exact wavelength and dose.
• Blue light may be used in combination with red or near-infrared wavelengths.

What 465 nm does not automatically prove

The current evidence does not justify universal claims that 465 nm:

• Cures acne
• Prevents every future breakout
• Replaces acne medication
• Clears every type of acne
• Eliminates acne scars
• Is appropriate for every skin tone or pigmentary condition
• Produces the same outcome as a 415 nm study
• Is effective simply because it is blue

Blue light and pigmentation

Visible light can affect pigmentation.

Reviews report that visible light may produce erythema in lighter skin and more persistent pigmentation in darker skin under certain exposure conditions. These findings concern visible-light biology broadly and do not prove that every therapeutic blue-light mask causes pigmentation. They do mean that pigmentation risk should not be dismissed without considering wavelength, dose, skin tone and existing pigmentary conditions.

People with melasma, post-inflammatory hyperpigmentation, visible-light sensitivity or unexpected darkening after light exposure should consult a dermatologist before using a blue-light mode.

Read:

• At-Home LED Light for Acne-Prone Skin
• LED Light Therapy Across Different Skin Tones

630 nm red light

What is 630 nm light?

630 nm is visible red light.

It falls within a wavelength region commonly used in facial photobiomodulation research. Red-light studies have investigated outcomes involving:

• Fine lines
• Periocular wrinkles
• Skin roughness
• Participant satisfaction
• Skin texture
• Collagen-related measurements
• Signs associated with photoaging

The proposed mechanisms commonly involve cellular photoacceptors, mitochondrial activity and downstream signaling. Those mechanisms do not independently prove a visible result; human trials remain necessary.

Human research involving 630 nm

A 2023 facial study evaluated a mask emitting 630 ± 10 nm red light. Participants used the device twice weekly for three months, with each session lasting 12 minutes. The study reported improvements in several clinical and instrumental measures of facial aging. It tested a particular mask, dose and protocol—not RAVAYA.

A 2025 multicenter randomized, double-blind, sham-controlled trial evaluated a home-use mask combining 630 nm red light with 850 nm near-infrared light in 60 adults with crow’s-feet wrinkles. Differences between active treatment and sham treatment were reported during follow-up. This is especially relevant to the home-mask category, but it remains evidence for the tested device and protocol.

Earlier controlled studies also evaluated nearby red wavelengths such as 633 nm, sometimes combined with approximately 830 nm near-infrared light. These studies reported changes in clinical wrinkle assessments, skin texture, histological findings or collagen-related measures, but the devices, doses and study designs varied.

What 630 nm may reasonably be discussed for

The current evidence supports careful statements such as:

• 630 nm and nearby red wavelengths have been evaluated in controlled human facial-rejuvenation studies.
• Some studies report improvements in particular wrinkle, texture or photoaging measurements.
• Results generally developed over repeated sessions rather than one exposure.
• Outcomes depend on the tested device and protocol.

What 630 nm does not automatically prove

The presence of 630 nm LEDs does not, by itself, prove that a device:

• Produces a particular wrinkle-reduction percentage
• Works within a guaranteed number of weeks
• Rebuilds a defined quantity of collagen
• Lifts sagging skin
• Reshapes facial contours
• Is equivalent to a professional procedure
• Is safe at any dose
• Works equally well for every user

Collagen claims require context

Laboratory studies have reported collagen- and elastin-related changes after red and near-infrared exposure. Human studies have also reported some collagen-density or histological changes under specific treatment conditions.

The scientifically appropriate conclusion is not:

630 nm always stimulates enough collagen to create visibly firmer skin.

A more accurate statement is:

Certain laboratory and human studies using defined red-light devices and protocols have reported collagen-related changes and improvements in some measures of facial aging.

Read:

• 630 nm Red Light: Evidence and Limitations
• Red Light Therapy for Fine Lines and Wrinkles

850 nm near-infrared light

What is 850 nm light?

850 nm is near-infrared light and is ordinarily invisible to the human eye.

Near-infrared light generally undergoes different absorption and scattering than visible blue or red light. It is often discussed as reaching more deeply into tissue than shorter visible wavelengths, but an exact penetration depth cannot be inferred from wavelength alone.

Depth and delivered energy also depend on:

• Irradiance
• Device contact
• Angle
• Skin pigmentation
• Water and blood absorption
• Tissue scattering
• Treatment geometry
• Exposure time
• Measurement method

Longer wavelength should therefore not be used as a synonym for “more effective.”

Most facial research evaluates combinations

A central limitation in interpreting 850 nm is that much of the relevant facial research evaluates it together with red light.

The 2025 home-mask trial used 630 nm and 850 nm together. It therefore supports the combined protocol tested by the researchers; it does not isolate the contribution of 850 nm.

A 2020 home-use study evaluated a combination of 660 nm and 850 nm light along with topical hyaluronic acid in people with photoaged facial skin. Because the study combined two wavelengths and a topical treatment, it cannot determine what 850 nm alone contributed.

Another home-use study used 637 nm and 854 nm as an adjunctive treatment for facial rejuvenation. Again, the near-infrared wavelength was part of a combination rather than an isolated intervention.

What 850 nm may reasonably be discussed for

Careful educational statements may explain that:

• 850 nm is commonly paired with red light in facial PBM devices.
• Controlled human studies have evaluated red-and-850 nm combinations.
• Combination studies have reported improvements in some facial-aging measures.
• The specific contribution of 850 nm is difficult to separate when multiple wavelengths are delivered together.

What 850 nm does not automatically prove

The available facial-mask evidence does not establish that isolated 850 nm:

• Treats pigmentation
• Heals post-procedure skin
• Reduces inflammation in every skin condition
• Boosts circulation to a clinically meaningful degree
• Is safe immediately after surgery
• Produces wrinkle reduction on its own
• Reaches a precise number of millimeters into every user’s skin
• Improves lymphatic drainage
• Is automatically superior to red light

Read 850 nm Near-Infrared Light Explained.

1070 nm near-infrared light

What is 1070 nm light?

1070 nm is a longer near-infrared wavelength.

RAVAYA currently describes 1070 nm as “Deep Near-Infrared.” This is a product-facing label intended to distinguish it from the mask’s 850 nm channel. The scientific question remains whether 1070 nm produces meaningful and reproducible outcomes at the dose, geometry and treatment schedule delivered by the finished mask.

How much research exists?

The human skin-rejuvenation evidence at approximately 1070–1072 nm is much smaller than the evidence surrounding conventional red wavelengths and red-plus-shorter-NIR combinations.

A randomized, double-blind, placebo-controlled self-report study published in 2007 evaluated regular 1072 nm treatment around the eyes. Some participants reported improvement in fine lines, wrinkles and under-eye bags. The study relied heavily on self-reported assessments and does not provide the same degree of confidence as a modern trial with validated objective measurements and strong device reporting.

A 2023 review of 1072 nm cutaneous research described possible applications and theoretical advantages but emphasized that clinical research at this wavelength remained limited.

A systematic review of randomized dermatology LED trials also identified a placebo-controlled 1072 nm study reporting self-assessed improvement in skin texture. This remains a relatively small portion of the overall LED dermatology literature.

Other 1072 nm studies do not automatically apply

1072 nm has also been studied for applications such as herpes labialis.

A randomized trial reported a shorter cold-sore healing time with a 1072 nm device compared with placebo. That study involved a different condition, treatment area, device design and intended use. It cannot be used to prove facial rejuvenation, wrinkle reduction or contouring.

This is an example of why RAVAYA separates study quality from product applicability.

What 1070 nm may reasonably be discussed for

The available research supports statements such as:

• Approximately 1070–1072 nm has been investigated in limited human skin studies.
• Some preliminary research has reported self-assessed improvement in facial-aging measures.
• Additional controlled, independently replicated research is needed.
• Exact-product testing is needed to determine RAVAYA’s output and delivered dose.

What 1070 nm does not currently establish

The studies identified for this guide do not establish that a consumer facial mask using 1070 nm:

• Reaches facial muscles at an effective dose
• Tones facial muscles
• Lifts sagging tissue
• Sculpts the jawline
• Drains lymphatic fluid
• Treats joints through a facial mask
• Produces superior wrinkle results to 630 or 850 nm
• Creates a long-term tightening effect
• Works because it is the “deepest” wavelength
• Reaches an exact universal depth such as 10 mm

Claims involving muscle treatment, facial lifting, contouring and lymphatic drainage would require direct human evidence using the exact product or a highly comparable device and validated outcome measurements.

Read 1070 nm Near-Infrared Light: Evidence and Limitations.

Why penetration depth should be described carefully

Online wavelength charts often show a simple progression:

Blue stays near the surface, red enters the dermis, near-infrared reaches deeper tissue.

This can be a useful introductory concept, but it becomes misleading when presented as a precise anatomical map.

Light in tissue is:

• Reflected
• Scattered
• Absorbed
• Redirected
• Attenuated

Visible and near-infrared light can interact with multiple skin layers, and the amount reaching a particular depth depends on more than wavelength. Reviews of visible-light biology note that visible light can interact throughout the skin and produce effects such as erythema and pigmentation under certain exposure conditions.

A responsible wavelength diagram should therefore show relative interaction, not unverified exact depths.

RAVAYA should not publish a penetration-depth number until the basis for that number is documented and reviewed by an appropriate optical expert.

Why wavelength alone cannot determine dose

A device can use a research-supported wavelength while delivering a substantially different exposure from the research.

Consider two hypothetical 630 nm devices:

• Device A delivers low irradiance over a long session.
• Device B delivers higher irradiance over a shorter session.
• Their LED spacing and facial coverage differ.
• One pulses and one operates continuously.
• One sits close to the skin and one sits farther away.

The nominal wavelength matches, but the treatment is not identical.

Important specifications include:

Irradiance

The rate of light power delivered over an area, commonly expressed in mW/cm².

Fluence or radiant exposure

The total light energy delivered over an area, commonly expressed in J/cm².

Treatment time

The length of exposure.

Pulse behavior

Whether the LEDs operate continuously or switch on and off.

Coverage and uniformity

How evenly the light is delivered across the treatment area.

Read Irradiance, Joules and Delivered Dose for the complete explanation.

How RAVAYA currently combines its wavelengths

The current RAVAYA website lists the following wavelength combinations. The benefit language should be reviewed separately; this table records only the published mode names and wavelength configurations.

Before publication, verify this table against:

• The final user manual
• Firmware or controller behavior
• Electrical specifications
• Optical testing
• Regulatory documentation
• Approved intended-use language

The complete mode article should explain each mode without implying that a combination’s name proves its outcome.

Read Complete Guide to the Five RAVAYA Modes after publication.

Does combining wavelengths make treatment more effective?

Not necessarily.

Combining wavelengths may make sense when:

• The wavelengths have different biological targets.
• The combination was tested as a complete protocol.
• The total delivered dose remains appropriate.
• The device distributes each wavelength adequately.
• The intended outcome is supported by relevant evidence.

But more wavelengths do not automatically mean:

• Greater effectiveness
• Faster results
• Deeper treatment
• Better safety
• A larger clinical benefit
• More collagen
• Better acne outcomes

Combination studies cannot always determine which wavelength produced which portion of the result.

For example, a 630 nm and 850 nm trial can support the tested combination but may not show whether:

• 630 nm caused most of the result.
• 850 nm caused most of the result.
• Both were required.
• The same outcome would occur with a different dose ratio.
• Adding 1070 nm would improve the outcome.

A multiwavelength device should ultimately be evaluated as a finished system.

Wavelengths and RAVAYA evidence grades

Under the RAVAYA Evidence-Grading Methodology, the current wavelength evidence would generally be interpreted as follows:

465 nm

Preliminary-to-comparable category evidence

Broader blue-light acne evidence exists, but much of it uses wavelengths closer to 415 nm. Direct evidence involving exact 465 nm consumer-mask treatment is more limited.

630 nm

Strong comparable human evidence

Controlled human facial studies have evaluated 630 nm or very nearby red wavelengths, including mask-based treatment.

850 nm

Strong-to-limited combination evidence

Relevant human studies commonly evaluate 850 nm with red light. The combination evidence is stronger than evidence for isolated 850 nm facial treatment.

1070 nm

Limited human evidence

A small number of human studies and reviews exist, but the evidence remains preliminary and does not support broad lifting, sculpting or muscle-treatment claims.

These are category-level assessments. RAVAYA-specific clinical evidence would require research using the exact finished product.

Safety considerations differ by wavelength

Blue light

Particular care may be appropriate for:

• Melasma
• Post-inflammatory hyperpigmentation
• Visible-light-sensitive conditions
• Unexpected pigment changes
• Certain photosensitizing products or medications

Red and near-infrared light

Users should still follow:

• Eye-protection instructions
• Session limits
• Medication precautions
• Device warnings
• Heat and malfunction guidance

Invisible near-infrared output should not be assumed harmless merely because it cannot be seen.

Read LED Light Therapy Safety and Suitability before beginning a new light-therapy routine.

Frequently asked questions

Which RAVAYA wavelength is best?

There is no universally “best” wavelength.

The appropriate mode depends on:

• The intended use
• Device instructions
• Evidence supporting the exact mode
• Skin condition
• Safety considerations
• Approved treatment schedule

Is 1070 nm better because it is deeper?

No.

A longer wavelength may interact differently with tissue, but greater potential depth does not guarantee a useful biological dose or a better cosmetic result.

Is 465 nm the same as the 415 nm blue light used in many acne studies?

No.

Both are blue visible light, but a 50 nm difference is meaningful. Evidence at 415 nm can inform the broader blue-light rationale but should not be presented as direct proof of 465 nm performance.

Does 630 nm increase collagen?

Certain laboratory and human studies have reported collagen-related changes under defined red-light protocols. That does not mean every 630 nm device produces the same collagen response.

What can 850 nm do by itself?

The isolated effect is difficult to determine from combination studies. Much of the relevant facial-mask research evaluates 850 nm together with red light.

Does 1070 nm tone facial muscles?

The human studies identified for this guide do not establish facial-muscle toning, lifting or jawline sculpting from a 1070 nm consumer mask.

Can I use every mode during one session?

Only when the approved RAVAYA instructions expressly permit it. Do not stack modes or increase total exposure based on wavelength descriptions alone.

Does more wavelengths mean better results?

No. Device quality, evidence, dose, coverage, safety and consistency matter more than the number of wavelengths listed.

Why can’t I see 850 or 1070 nm LEDs?

These wavelengths are ordinarily outside the visible range. An LED can be operating even when its emitted near-infrared light cannot be seen.

Are these “FDA-approved wavelengths”?

No.

FDA regulatory status applies to a specific device and its specified intended use, not to a wavelength in isolation.

Related RAVAYA resources

• Complete Guide to At-Home LED Light Therapy
• How Photobiomodulation Works
• Irradiance, Joules and Delivered Dose
• LED Light Therapy Safety and Suitability
• How RAVAYA Grades Scientific Evidence
• Complete Guide to the Five RAVAYA Modes
• RAVAYA Research Library
• RAVAYA Testing and Transparency Center

Editorial evidence statement

This article summarizes research involving blue, red and near-infrared light.

Unless expressly stated, the cited studies did not test the RAVAYA Advanced-Spectrum Mask.

A matching or nearby wavelength does not establish identical:

• Spectral output
• Irradiance
• Dose
• Pulse behavior
• Coverage
• Treatment schedule
• Safety
• Intended use
• Clinical outcome

RAVAYA-specific conclusions require applicable documentation or testing of the exact finished product.

This article is educational and is not personal medical advice.

Selected references

• Ershadi S, et al. At-Home LED Devices for the Treatment of Acne Vulgaris: A Systematic Review and Meta-Analysis.
• Scott AM, et al. Blue-Light Therapy for Acne Vulgaris: A Systematic Review and Meta-Analysis.
• Papageorgiou P, et al. Phototherapy With Blue and Red Light in Acne Vulgaris.
• Couturaud V, et al. Reverse Skin Aging Signs by Red Light Photobiomodulation.
• Park SH, et al. Home-Use 630 nm and 850 nm LED Mask for Crow’s Feet.
• Lee SY, et al. Clinical, Profilometric and Histologic Evaluation of 633 nm and 830 nm LED Phototherapy.
• Wunsch A, Matuschka K. Controlled Red and Near-Infrared Light Trial Evaluating Fine Lines, Roughness and Collagen Density.
• Kim DS, et al. 660 nm and 850 nm Home-Use LED Mask With Topical Hyaluronic Acid.
• Stirling RJ, et al. Self-Reported Clinical Trial of 1072 nm Light as an Anti-Aging Agent.
• Mineroff J, et al. Cutaneous Effects of Photobiomodulation With 1072 nm Light.
• Austin E, et al. Properties and Cutaneous Effects of Visible Light.
• Moon JY, et al. Utilization of Light-Emitting Diodes for Skin Therapy: Systematic Review and Meta-Analysis.

Page history

Effective: July 31, 2026Current version: 1.0Scientific review: PendingMedical review: PendingRAVAYA spectral-output verification: PendingRAVAYA-specific clinical evidence used: No